Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study

Intravenous (IV) drug administration enables treatment of epilepsy when oral administration is temporarily not feasible. Perampanel is a once‐daily antiseizure medication currently available as oral formulations. Study 050 (NCT03376997) was an open‐label, randomized, single‐dose, crossover study to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Ziad, Majid, Oneeb, Boyd, Peter, Aluri, Jagadeesh, Ngo, Leock Y, Reyderman, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320958/
https://www.ncbi.nlm.nih.gov/pubmed/35596529
http://dx.doi.org/10.1002/cpdd.1107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320958/
https://www.ncbi.nlm.nih.gov/pubmed/35596529
http://dx.doi.org/10.1002/cpdd.1107

Ejemplares similares